Literature DB >> 30728673

The Differential Influence of Immunological Process of Autoimmune Disease on Lipid Metabolism: A Study on RA and SLE.

S Chandrashekara1, Sachin Vithalrao Dhote1, K R Anupama1.   

Abstract

Metabolic parameters like uric acid, lipids and homocysteine are influenced by immunopathological mechanisms underlying the autoimmune disease processes. The current study examined the differences in these parameters and the correlation between inflammatory and metabolic variables in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) patients. The cross-sectional prospective study included 24 treatment-naïve patients with moderate to severe diseases-15 subjects had RA and 9 had SLE. Atherogenic index of plasma (AIP) was used to assess the cardiovascular risk of the patients. Spearman's correlation was performed to verify the relationship between inflammatory and metabolic parameters. A two-tailed P < 0.05 was considered statistically significant for all the analysis. SLE patients had higher uric acid levels, very low density lipoprotein-cholesterol, total cholesterol/high density lipoprotein-cholesterol ratio (TC/HDL-C) and logarithmic ratio of triglycerides to HDL-cholesterol (log[TG/HDL-C]) than RA. Whereas, reduced total lymphocyte count, lipoprotein(a), and low density lipoprotein cholesterol were noted in the former than latter group. Majority of the SLE patients had increased risk of cardiovascular diseases (> 0.24 AIP score) and RA patients in comparison had lower risk. Correlation among serum uric acid, lipid profile constituents and AIP was noted. The immunological process of SLE has greater impact on the metabolic parameters. Higher uric acid levels are suggestive of dysfunctional lipid profile. Understanding the implications of risk factors and its inflammatory role in autoimmune processes may assist in disease management.

Entities:  

Keywords:  Atherogenic index; Autoimmune diseases; Immunopathologic process; Inflammatory process; Lipid metabolism; Serum uric acid

Year:  2017        PMID: 30728673      PMCID: PMC6346621          DOI: 10.1007/s12291-017-0715-9

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  40 in total

Review 1.  Accelerated atherosclerosis in autoimmune rheumatic diseases.

Authors:  Yehuda Shoenfeld; Roberto Gerli; Andrea Doria; Eiji Matsuura; Marco Matucci Cerinic; Nicoletta Ronda; Luis J Jara; Mahmud Abu-Shakra; Pier Luigi Meroni; Yaniv Sherer
Journal:  Circulation       Date:  2005-11-22       Impact factor: 29.690

Review 2.  Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis.

Authors:  F I Romero; M A Khamashta; G R Hughes
Journal:  Lupus       Date:  2000       Impact factor: 2.911

3.  Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.

Authors:  Daniel H Solomon; Elizabeth W Karlson; Eric B Rimm; Carolyn C Cannuscio; Lisa A Mandl; JoAnn E Manson; Meir J Stampfer; Gary C Curhan
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

4.  Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.

Authors:  J Delgado Alves; P R J Ames; S Donohue; L Stanyer; J Nourooz-Zadeh; C Ravirajan; D A Isenberg; J Noorouz-Zadeh
Journal:  Arthritis Rheum       Date:  2002-10

5.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.

Authors:  Emily C Baechler; Franak M Batliwalla; George Karypis; Patrick M Gaffney; Ward A Ortmann; Karl J Espe; Katherine B Shark; William J Grande; Karis M Hughes; Vivek Kapur; Peter K Gregersen; Timothy W Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

6.  Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus.

Authors:  M M Ward
Journal:  Arthritis Rheum       Date:  1999-02

Review 7.  Pathogenesis of systemic lupus erythematosus.

Authors:  C C Mok; C S Lau
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

8.  Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.

Authors:  Emese Kiss; Ildikó Seres; Tünde Tarr; Zsolt Kocsis; Gyula Szegedi; György Paragh
Journal:  Ann N Y Acad Sci       Date:  2007-06       Impact factor: 5.691

Review 9.  [AIP--atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice].

Authors:  M Dobiásová
Journal:  Vnitr Lek       Date:  2006-01

10.  Serum oxidized low-density lipoproteins in rheumatoid arthritis.

Authors:  Seong-Ho Kim; Chang-Keun Lee; Eun Young Lee; So Yeon Park; You Sook Cho; Bin Yoo; Hee-Bom Moon
Journal:  Rheumatol Int       Date:  2003-11-20       Impact factor: 2.631

View more
  1 in total

1.  Fasting triglycerides and glucose index: a useful screening test for assessing insulin resistance in patients diagnosed with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Betsabe Contreras-Haro; Sandra Ofelia Hernandez-Gonzalez; Laura Gonzalez-Lopez; Maria Claudia Espinel-Bermudez; Leonel Garcia-Benavides; Edsaul Perez-Guerrero; Maria Luisa Vazquez-Villegas; Jose Antonio Robles-Cervantes; Mario Salazar-Paramo; Diana Mercedes Hernandez-Corona; Arnulfo Hernan Nava-Zavala; Jorge I Gamez-Nava
Journal:  Diabetol Metab Syndr       Date:  2019-11-27       Impact factor: 3.320

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.